Novel use of alprazolam as a potential HIV-1 latency reversing agent by W. Elbezanti, A. Lin, S. Luca, F. Maldarelli, Z. Klase

Get full text

HIV viremia is the product of a small fraction of infected cells by E. Anderson, J. Bell, M. Kearney, J. Coffin, F. Maldarelli

Get full text

1 Analysis of intra-patient, full length HIV gagsequences identifies regions of variability by E. Anderson, M. Gouzoulis, A. Ganesan, C. Rehm, S. Jones, F. Maldarelli

Get full text

PP 3.16 – 00209 Prolonged persistence of HIV-infected cells in tissues after allogeneic hematopoietic transplant by F. Maldarelli, T. Nguyen, L. Adams, M. Zipparo, R. Gorelick, S. Hewitt, S. Rajan, P. Rubinstein, J. Kanakry

Get full text

Ultradeep analysis of pretherapy HIV predicts large and genetically complex reservoirs during antiretroviral therapy by K. Huik, J. Hattori, V. Boltz, J. Rausch, W. Shao, M. Kearney, J. Coffin, F. Maldarelli

Get full text

HIV proviruses with identical sequences arise from cell expansion and infection by a common ancestor virus by S. Patro, A. Niyongabo, S. Guo, X. Wu, E. Boritz, S. Deeks, F. Maldarelli, S. Hughes, J. Coffin, M. Kearney

Get full text

In vivo analysis of HIV from an occupational exposure to laboratory adapted HIV-IIIB with 20-year follow-up: implications for reservoir formation by C. Lange, N. Lindo, R. Little, T. Uldrick, S. Hill, J. Bell, K. Lurain, R. Ramaswami, R. Yarchoan, F. Maldarelli

Get full text

Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues by F. Maldarelli, M. Gozoulis, X. Wu, L. Perez, R. Gorelick, C. Lange, S. Hill, J. Virga, T. Uldrick, R. Yarchoan, S. Hughes

Get full text

P 4.2 – 00029 Innate Immune Correlates of Cell-Associated HIV RNA And DNA During Long-Term Suppressive ART by C.-Y. Lau, R. Gorelick, J. Earhart, J. Higgins, R. Dewar, D. McMahon, A. Ganesan, B. Luke, F. Maldarelli

Get full text

PP 3.17 – 00211 Genetic Diversity of HIV-1 Long Terminal Repeat in Proviral Populations During Long-Term Antiretroviral Therapy by T. Nguyen, M.E. Zipparo, L. Adams, A. Glassey, E. Madeen, U. Santamaria, C.A. Rehm, J. Earhart, C.Y. Lau, F. Maldarelli

Get full text

PP 3.2 – 00068 Differential transcriptional levels of HIV-1 near full-length and highly deleted proviruses by T. Nguyen, L. Adams, M.E. Zipparo, A. Glassey, U. Santamaria, C.A. Rehm, J. Earhart, W. Shao, C.Y. Lau, F. Maldarelli

Get full text

OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy by G. Bozzi, S. Watters, F.R. Simonetti, E. Anderson, R. Gorelick, W. Shao, J. Bell, C. Rehm, R. Dewar, R. Yarchoan, T. Uldrick, F. Maldarelli

Get full text

35 Therapy with the immunomodulatory agent pomalidomide does not lead to changes in HIV-1 viral populations in vivo by S.A. Watters, M.N. Polizzotto, W. Shao, R. Gorelick, E.M. Anderson, I. Sereti, K. Aleman, L. Kouyoudjian, J.B. Zeldis, T. Uldrick, R. Yarchoan, F. Maldarelli

Get full text

Interim safety analysis of cancer immunotherapy trials Network – 12 (CITN-12): a Phase 1 study of pembrolizumab in patients with HIV and cancer by T.S. Uldrick, M.A. ‘Mac’ Cheever, P.H. Gonçalves, S. Fling, K. Aleman, B. Emu, M.S. Ernstoff, R. Gorelick, J. Kaiser, H. E Kohrt, A. Lacroix, M. Lindsley, L. M Lundgren, K. Lurain, F. Maldarelli, C. Parsons, E. Sharon, A. Widell, R. Yarchoan

Get full text